Skip to main content

Table 3 Levothyroxine dosage prescribed in subclinical and overt hypothyroid subgroups as well as autoimmune and nonautoimmune subgroups according to trimester wise and preconception status

From: Levothyroxine dosages during pregnancy among hypothyroid women. An experience from a tertiary care center of Karachi, Pakistan, based on data from Maternal Hypothyroidism on Pregnancy Outcomes Study (MHPO-5)

 

Subclinical hypothyroidism

(N = 105)

(µg/day)

Overt hypothyroidism

(N = 50)

(µg/day)

Autoimmune hypothyroidism

(N = 78)

(µg/day)

Nonautoimmune hypothyroidism

(N = 202)

(µg/day)

Preconception dosage*

50.0 (50.0)

100.0 (41.8)

85.7 (66.0)

75.0 (50.0)

1st trimester dosage

64.3 (50.0)

100.0 (41.0)

100.0 (75.0)

100.0 (64.3)

2nd trimester dosage

71.4 (50.0)

100.0 (50.0)

100.0 (87.5)

100.0 (71.4)

3rd trimester dosage

78.5 (71.4)

110.7 (51.7)

103.5 (92.8)

100.0 (85.7)

  1. *Dosage reported as medians (IQR)